Allergan cites DTC spending as factor in strong Q2 results

Share this article:
Allergan cited strong spending behind DTC and detailing as factors in reporting stronger-than-expected Q2 results. The firm saw solid gains in its eyecare products, breast implants, medical devices for obesity and Botox for a 23% gain over Q2 2006.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions